24-hour top trending trials we're tracking at #ESMO26 as we start day 2, based on posts by validated HCPs on social media:
AMPLIFY-7P
TALAPRO-7
NATALEE
PANKU-Breast01
TNBC
PEARL
DeLLphi-305
KEYNOTE-365
For our #ESMO26 platform we're tracking HCP posts about every trial and product in the following tumour types:
#breastcancer
#lungcancer
#ovariancancer
#prostatecancer
#colorectalcancer
...and so can you, with our complimentary access programme during ESMO only - just sign up at http://intelligence.creation.co
14 views · 0 likes · 0 reposts · 0 replies
Adjuvant ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HR+/HER2− early breast cancer (EBC): NATALEE 6-y overall survival (OS) and efficacy outcomes
https://esmocongress.esmo.orgSource: Daniel Ghinn · x.com